Valuation : BrainsWay Ltd.

Market Cap 578M 1.74B 497M 466M 427M 796M 54.61B 803M 5.52B 2.15B 27.91B 2.17B 2.12B 89.87B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 578M 1.74B 497M 466M 427M 796M 54.61B 803M 5.52B 2.15B 27.91B 2.17B 2.12B 89.87B EV / Sales 2026 *
8.35x
EV / Sales 2027 * 6.77x
Free-Float
90.5%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 54 13/02/2023
Chief Tech/Sci/R&D Officer 56 01/05/2006
Director of Finance/CFO 50 23/05/2023
Director TitleAgeSince
Director/Board Member 50 05/11/2024
Director/Board Member 75 03/12/2017
Chairman 55 13/02/2023
Change 5-day change 1-year change 3-year change Capi.($)
+10.37%+15.65% - - 578M
+1.63%-1.95%+27.63%+10.98% 229B
+0.53%-2.16%+5.81%-20.54% 148B
-0.55%+0.75%-16.17%+19.14% 131B
-2.94%+0.60%-56.34%-12.44% 68.04B
-1.15%-0.19%+10.54%+17.54% 51.75B
+0.97%-0.86%-16.89%-14.02% 50.21B
-0.93%-4.89%+19.77%+23.03% 42.28B
+0.33%-1.83%+42.58%+47.16% 40.63B
-0.73%-2.79%-14.87%+43.97% 33.06B
Average +1.25%-1.35%+0.23%+12.76% 88.18B
Weighted average by Cap. +0.66%-1.78%+3.79%+7.14%

Financials

2026 *2027 *
Net sales 69.16M 208M 59.51M 55.84M 51.09M 95.36M 6.54B 96.11M 661M 257M 3.34B 260M 254M 10.76B 85.33M 257M 73.42M 68.9M 63.04M 118M 8.07B 119M 815M 317M 4.12B 320M 313M 13.28B
Net income 12.38M 37.24M 10.65M 10M 9.15M 17.07M 1.17B 17.21M 118M 46.06M 598M 46.5M 45.49M 1.93B 20.96M 63.04M 18.04M 16.93M 15.49M 28.91M 1.98B 29.13M 200M 77.98M 1.01B 78.73M 77.01M 3.26B
Net Debt - -
Logo BrainsWay Ltd.
Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.
Employees
-